• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2021年204个国家和地区慢性呼吸道疾病负担及其可归因风险因素:全球疾病负担研究2021结果

Burden of chronic respiratory diseases and their attributable risk factors in 204 countries and territories, 1990-2021: Results from the global burden of disease study 2021.

作者信息

Cao Zhong, He Liu, Luo Yuheng, Tong Xunliang, Zhao Jinghan, Huang Ke, Chen Qiushi, Jiao Lirui, Liu Yuhao, Geldsetzer Pascal, Yang Ting, Wang Chen, Bärnighausen Till Winfried, Chen Simiao

机构信息

Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg 69120, Germany.

Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

出版信息

Chin Med J Pulm Crit Care Med. 2025 Jun 14;3(2):100-110. doi: 10.1016/j.pccm.2025.05.005. eCollection 2025 Jun.

DOI:10.1016/j.pccm.2025.05.005
PMID:40677417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12266273/
Abstract

BACKGROUND

Chronic respiratory diseases (CRDs) remain a substantial global public health challenge, contributing significantly to morbidity and mortality worldwide. This study aimed to comprehensively characterize trends in CRD burden across various populations by examining differences by sex, age, and sociodemographic index (SDI).

METHODS

We performed a systematic analysis using data from the Global Burden of Disease (GBD) 2021 study, covering the period from 1990 to 2021 across 204 countries and territories. Estimates of age-standardized prevalence, mortality, disability-adjusted life years (DALYs), incidence, and annualized percentage changes for both 1990-2021 and 2019-2021 were calculated. Geographic and demographic variations were evaluated by age, sex, and SDI. The contributions of key risk factors-including tobacco use, ambient particulate matter (PM) pollution, household air pollution from solid fuels, and occupational exposure to PM, gases, and fumes-were also assessed.

RESULTS

In 2021, an estimated 468.3 million individuals globally were living with CRDs, with an age-standardized prevalence rate of 5785.4 per 100,000 population. CRDs accounted for 4.4 million deaths with age-standardized mortality rate of 53.6 per 100,000 population and 108.5 million DALYs with age-standardized DALY rate of 1294.6 per 100,000 population in the same year. Age-standardized prevalence rate decreased by 1.01 % from 1990 to 2021 but increased by 0.20 % from 2019 to 2021. From 2019 to 2021, the age-standardized incidence rate of CRDs increased slightly from 713.4 to 719.3 per 100,000 population, with an annualized percentage change of 0.41 %, while the age-standardized DALY rate continued to decline from 1321.9 to 1294.6 per 100,000 population, with an annualized percentage change of -1.04 %. Although the age-standardized mortality rate declined by 1.46 % over the full period, the absolute number of deaths rose as a result of demographic shifts, including population growth and aging. Globally, tobacco use remained the predominant risk factor, while household air pollution from solid fuels was the leading contributor to DALYs and mortality in low- and low-middle SDI countries.

CONCLUSION

The global burden of CRDs remains both substantial and dynamic, underscoring the continued influence of risk factors such as tobacco use and household air pollution. These findings emphasize the urgent need for targeted public health interventions and more equitable healthcare resource allocation, particularly in low- and middle-SDI regions. Strengthened surveillance systems, improved access to care, and integrated strategies addressing both established and emerging risk factors are essential for reducing the global impact of CRDs.

摘要

背景

慢性呼吸道疾病(CRDs)仍然是一项重大的全球公共卫生挑战,在全球范围内对发病率和死亡率有重大影响。本研究旨在通过研究性别、年龄和社会人口学指数(SDI)的差异,全面描述不同人群中CRD负担的趋势。

方法

我们使用全球疾病负担(GBD)2021研究的数据进行了系统分析,涵盖了1990年至2021年期间204个国家和地区。计算了1990 - 2021年以及2019 - 2021年年龄标准化患病率、死亡率、伤残调整生命年(DALYs)、发病率和年化百分比变化。按年龄、性别和SDI评估地理和人口差异。还评估了关键风险因素的贡献,包括烟草使用、环境颗粒物(PM)污染、固体燃料造成的家庭空气污染以及职业接触PM、气体和烟雾。

结果

2021年,全球估计有4.683亿人患有CRDs,年龄标准化患病率为每10万人5785.4例。同年,CRDs导致440万人死亡,年龄标准化死亡率为每10万人53.6例,1.085亿伤残调整生命年,年龄标准化DALY率为每10万人1294.6例。年龄标准化患病率从1990年到2021年下降了1.01%,但从2019年到2021年上升了0.20%。从2019年到2021年,CRDs的年龄标准化发病率从每10万人713.4例略有上升至719.3例,年化百分比变化为0.41%,而年龄标准化DALY率继续从每10万人1321.9例下降至1294.6例,年化百分比变化为 - 1.04%。尽管在整个期间年龄标准化死亡率下降了1.46%,但由于人口结构变化,包括人口增长和老龄化,死亡绝对数有所上升。在全球范围内,烟草使用仍然是主要风险因素,而固体燃料造成的家庭空气污染是低SDI和低中SDI国家DALYs和死亡率的主要促成因素。

结论

CRDs的全球负担仍然既重大又动态,凸显了烟草使用和家庭空气污染等风险因素的持续影响。这些发现强调迫切需要有针对性的公共卫生干预措施和更公平的医疗资源分配,特别是在低中SDI地区。加强监测系统、改善医疗服务可及性以及应对既定和新出现风险因素的综合策略对于减少CRDs的全球影响至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12266273/2da0a0f39d78/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12266273/2da0a0f39d78/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ed/12266273/2da0a0f39d78/gr1.jpg

相似文献

1
Burden of chronic respiratory diseases and their attributable risk factors in 204 countries and territories, 1990-2021: Results from the global burden of disease study 2021.1990 - 2021年204个国家和地区慢性呼吸道疾病负担及其可归因风险因素:全球疾病负担研究2021结果
Chin Med J Pulm Crit Care Med. 2025 Jun 14;3(2):100-110. doi: 10.1016/j.pccm.2025.05.005. eCollection 2025 Jun.
2
Burden of knee osteoarthritis in China and globally: 1990-2045.中国及全球膝关节骨关节炎负担:1990 - 2045年
BMC Musculoskelet Disord. 2025 Jul 1;26(1):582. doi: 10.1186/s12891-025-08858-8.
3
Global burden of vision impairment due to age-related macular degeneration, 1990-2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.1990年至2021年因年龄相关性黄斑变性导致的视力损害全球负担,以及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Glob Health. 2025 Jul;13(7):e1175-e1190. doi: 10.1016/S2214-109X(25)00143-3.
4
Global, regional, and national burden of IHD attributable to PM pollution aged 70 and above: an age-period-cohort modeling and frontiers analysis study.70岁及以上人群中因细颗粒物污染导致的缺血性心脏病的全球、区域和国家负担:一项年龄-时期-队列建模与前沿分析研究
Front Public Health. 2025 Jun 4;13:1573599. doi: 10.3389/fpubh.2025.1573599. eCollection 2025.
5
Global pattern, trend and cross-country inequalities of inguinal, femoral, and abdominal hernia among individuals aged 60 and above from 1990 to 2021 and projections until 2040: a population-based study.1990年至2021年60岁及以上人群腹股沟疝、股疝和腹疝的全球模式、趋势及国家间不平等状况以及至2040年的预测:一项基于人群的研究
Surg Endosc. 2025 May 28. doi: 10.1007/s00464-025-11810-5.
6
Global trends in testicular and prostate cancer among adolescents and young adult males aged 15-49 years, 1990-2021: insights from the GBD study.1990年至2021年15至49岁青少年及青年男性睾丸癌和前列腺癌的全球趋势:来自全球疾病负担研究的见解
Sci Rep. 2025 Jul 2;15(1):23388. doi: 10.1038/s41598-025-07361-3.
7
Burden of chronic obstructive pulmonary disease and risk factors in China from 1990 to 2021: Analysis of global burden of disease 2021.1990年至2021年中国慢性阻塞性肺疾病负担及危险因素:全球疾病负担研究2021分析
Chin Med J Pulm Crit Care Med. 2025 Jun 14;3(2):132-140. doi: 10.1016/j.pccm.2025.05.004. eCollection 2025 Jun.
8
Rising incidence and clinical impact of kidney cancer in China and worldwide: a call for targeted prevention, early diagnosis, and equitable treatment.中国及全球肾癌发病率上升及其临床影响:呼吁进行针对性预防、早期诊断和公平治疗。
Transl Androl Urol. 2025 May 30;14(5):1391-1407. doi: 10.21037/tau-2024-750. Epub 2025 May 27.
9
Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021.1990年至2021年全球、区域和国家软组织及其他骨外肉瘤的负担与趋势
Cancer Control. 2025 Jan-Dec;32:10732748251355841. doi: 10.1177/10732748251355841. Epub 2025 Jun 28.
10
Global Burden of Musculoskeletal Disorders in Adults Aged 50 and Over, 1990-2021: Risk Factors and Sociodemographic Inequalities.1990 - 2021年50岁及以上成年人肌肉骨骼疾病的全球负担:风险因素和社会人口不平等
J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70008. doi: 10.1002/jcsm.70008.

引用本文的文献

1
Letter to the editor regarding: 'global, regional, and national burden of chronic respiratory diseases, 1990-2021 and predictions to 2035: analysis of data from the global burden of disease study 2021'.致编辑的信:关于“1990 - 2021年慢性呼吸道疾病的全球、区域和国家负担及到2035年的预测:全球疾病负担研究2021数据分析”
Ann Med. 2025 Dec;57(1):2548972. doi: 10.1080/07853890.2025.2548972. Epub 2025 Aug 20.
2
WeChat-assisted strategies for personalized health management in patients with AECOPD: A randomized controlled trial.微信辅助的慢性阻塞性肺疾病急性加重期患者个性化健康管理策略:一项随机对照试验。
PLoS One. 2025 Aug 18;20(8):e0330673. doi: 10.1371/journal.pone.0330673. eCollection 2025.

本文引用的文献

1
Epidemiology of coal miners' pneumoconiosis and its social determinants: An ecological study from 1949 to 2021 in China.煤矿工人尘肺病的流行病学及其社会决定因素:1949年至2021年中国的一项生态学研究
Chin Med J Pulm Crit Care Med. 2023 Apr 28;1(1):46-55. doi: 10.1016/j.pccm.2023.03.002. eCollection 2023 Mar.
2
Forecasting the global burden of disease to 2050.预测到2050年的全球疾病负担。
Lancet. 2024 May 18;403(10440):1961-1963. doi: 10.1016/S0140-6736(24)00932-2.
3
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
4
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
5
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
6
Tobacco control in China.中国的烟草控制。
Lancet Public Health. 2023 Dec;8(12):e1006-e1015. doi: 10.1016/S2468-2667(23)00242-6.
7
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study.2020-50 年全球 204 个国家和地区慢性阻塞性肺疾病的全球经济负担:一项健康增强型宏观经济建模研究。
Lancet Glob Health. 2023 Aug;11(8):e1183-e1193. doi: 10.1016/S2214-109X(23)00217-6.
8
Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019.1990 - 2019年慢性呼吸道疾病及其风险因素的全球负担:全球疾病负担研究2019年的最新情况
EClinicalMedicine. 2023 May;59:101936. doi: 10.1016/j.eclinm.2023.101936.
9
Tobacco Product Use Among Adults - United States, 2021.成年人烟草制品使用情况 - 美国,2021 年。
MMWR Morb Mortal Wkly Rep. 2023 May 5;72(18):475-483. doi: 10.15585/mmwr.mm7218a1.
10
Global, regional, and national burden of chronic respiratory diseases and associated risk factors, 1990-2019: Results from the Global Burden of Disease Study 2019.1990-2019年全球、区域和国家慢性呼吸道疾病及相关危险因素负担:全球疾病负担研究2019的结果
Front Med (Lausanne). 2023 Mar 28;10:1066804. doi: 10.3389/fmed.2023.1066804. eCollection 2023.